Generated June 12, 2026 at 8:34 PM ET
· Covers June 12 trading day
· 10 of 293 ready 8-Ks selected
· AI-assisted overview
The day's filings featured several companies facing Nasdaq or NYSE American listing issues, including MicroVision's transfer application, Genprex's delisting notice, Perfect Moment's move to OTC, and Soligenix's bid price deficiency. Major M&A activities included Centessa shareholder approval of the Lilly acquisition, UniFirst shareholder approval of the Cintas deal with an FTC second request, and Eva Live increasing its stake in Spiro Senior Living. Sleep Number filed for Chapter 11 with a stalking horse sale agreement. Other notable items were Ameris Bancorp's $79.4M jury verdict in a wrongful termination suit, Socket Mobile's CEO removal, and Soligenix terminating its HyBryte program after a Phase 3 futility determination.
leadership
negative
materiality 0.80
June 12, 2026, 4:05 PM ET
Socket Mobile removes CEO Kevin Mills, appoints David A. Holmes as President and CEO
- Kevin Mills removed as President/CEO on June 8, 2026; placed on paid administrative leave pending termination.
- David A. Holmes appointed President and CEO effective June 12, 2026; previously Chief Business Officer since May 2021.
- Holmes has over 20 years of experience in NFC and mobile payments; held roles at NXP, Identive Group, and UL Solutions.
regulatory
negative
materiality 0.90
June 12, 2026, 5:04 PM ET
MicroVision applies to transfer to Nasdaq Capital Market, files new S-3, schedules shareholder update
- Applied to transfer listing from Nasdaq Global Market to Capital Market to gain up to 180 additional days to meet $1.00 minimum bid price requirement.
- Filed new registration statement on Form S-3 to replace expiring shelf, maintaining $42 million in remaining ATM availability as of March 31, 2026.
- Scheduled a business update and interactive Q&A session for shareholders on June 25, 2026, to discuss commercial progress and strategic initiatives.
CNTA
Centessa Pharmaceuticals plc
M&A
positive
materiality 0.90
June 12, 2026, 4:15 PM ET
Centessa shareholders approve Lilly acquisition; court sanction hearing June 22
- Shareholders voted 126,653,456 for vs 23,007 against (99.98% of votes cast) to approve the scheme of arrangement.
- All seven shareholders of record voted in favor; no shareholder voted against.
- Court sanction hearing scheduled for June 22, 2026 at Royal Courts of Justice, London.
regulatory
negative
materiality 0.85
June 12, 2026, 5:05 PM ET
Genprex receives Nasdaq delisting notice due to sub-$1 bid price; ineligible for compliance period
- Nasdaq staff determined on June 10, 2026 to delist GNPX due to bid price below $1.00 for 30 consecutive days.
- Company is ineligible for a 180-day compliance period because it effected a reverse stock split on October 21, 2025.
- Genprex intends to timely request a hearing before a Nasdaq Hearings Panel, which will stay delisting pending outcome.
M&A
positive
materiality 0.85
June 12, 2026, 8:13 AM ET
UniFirst shareholders approve Cintas acquisition; FTC issues second request
- 99%+ of votes cast in favor (47,458,203 for, 10,251 against) with ~95% of outstanding shares voted.
- Consideration: $155.00 cash + 0.7720 Cintas shares per UniFirst share.
- FTC issued Second Request under HSR Act, extending waiting period until 30 days after substantial compliance.
litigation
negative
materiality 0.85
June 12, 2026, 5:20 PM ET
Jury awards $79.4M against Ameris Bank in wrongful termination suit; company to appeal
- Jury awarded $16.525M in economic/non-economic damages plus statutory penalties and $62.9M in punitive damages.
- Plaintiff Patrick Byrne was CEO of Ameris Bank's equipment finance division from Dec 2021 to June 2024.
- Company disagrees with verdict, believes unsupported by facts or law, and intends to appeal.
regulatory
negative
materiality 0.75
June 12, 2026, 5:27 PM ET
Perfect Moment delisted from NYSE American; moves to OTC Markets after failing equity compliance
- NYSE American staff determined company failed to regain minimum stockholders' equity compliance after 18-month plan period; no appeal.
- Common stock to be suspended from NYSE American week of June 15, 2026; trading on OTCQB immediately under same ticker PMNT.
- Company cites cost savings and operational flexibility; will remain subject to SEC periodic reporting requirements.
M&A
positive
materiality 0.70
June 12, 2026, 9:35 AM ET
EVA Live increases ownership interest to 51% in Spiro Senior Living
- EVA Live (GOAI) to hold 51% controlling interest in Spiro Senior Living and related operating entities; definitive agreement expected to close on or about July 1, 2026.
- Spiro Senior has opened three senior healthcare facilities and is generating revenue exceeding expectations; expanding through Meridian Senior Living partnership.
- The partnership targets an AI-enabled engagement platform for senior care, aiming for recurring revenue from subscriptions, healthcare integrations, and digital care services.
other material
negative
materiality 0.95
June 12, 2026, 10:26 AM ET
Sleep Number files Chapter 11; agrees to $415M sale to Sleep Country Canada subsidiary
- Filed Chapter 11 on June 12, 2026; Stalking Horse Purchase Agreement with SNBR, Inc. (Sleep Country Canada) for $415M cash.
- Debtor-in-possession financing expected up to $260M, including $65M new money and $195M roll-up of prepetition debt.
- Prepetition debt of ~$672.5M in default and accelerated, subject to automatic stay.
other material
negative
materiality 0.85
June 12, 2026, 4:05 PM ET
Soligenix terminates HyBryte program after Phase 3 futility; receives Nasdaq bid price deficiency notice
- Received Nasdaq notice for non-compliance with $1.00 minimum bid price; 180 days until Dec 7, 2026 to regain compliance.
- Board terminated HyBryte (synthetic hypericin) development program after DMC recommended halt for futility.
- Expected wind-down charges of approximately $70,000 from closing FLASH2 trial.